{
  "ticker": "JNJ",
  "key": "JNJ_Q4_2025",
  "year": 2025,
  "quarter": 4,
  "verified_at": "2026-02-13T17:39:35.614953",
  "claims_with_verdicts": [
    {
      "claim": {
        "speaker_role": "ceo",
        "qualifiers": [
          "over"
        ],
        "claim_type": "absolute",
        "metric_context": "Total",
        "metric_type": "other",
        "gaap_classification": "unknown",
        "quote_end_char": 3746,
        "speaker": "Joaquin Duato",
        "quote_text": "In 2025, we invested over $32 billion in R&D and M&A, including the acquisitions of Intracellular Therapies and Halda Therapeutics.",
        "unit": "dollars",
        "quote_start_char": 3615,
        "period": "FY 2025",
        "claimed_value_raw": "$32 billion",
        "claim_id": "claim_001",
        "scale": "billions",
        "is_approximate": false,
        "confidence": 1,
        "claimed_value": 32
      },
      "verification": {
        "claim_id": "claim_001",
        "claimed_value": 32,
        "actual_value": 14665000000.0,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [
          {
            "field": "research_and_development",
            "fy": 2025,
            "fq": 1,
            "value": 3225000000
          },
          {
            "field": "research_and_development",
            "fy": 2025,
            "fq": 2,
            "value": 3516000000
          },
          {
            "field": "research_and_development",
            "fy": 2025,
            "fq": 3,
            "value": 3672000000
          },
          {
            "field": "research_and_development",
            "fy": 2025,
            "fq": 4,
            "value": 4252000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [
          "value_exceeds_actual"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Claimed value (32,000,000,000) is 2.2x the reported research and development (14,665,000,000). This likely reflects a different time period (TTM, annual, or fiscal year offset) or includes items beyond this metric.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "quote_end_char": 4201,
        "scale": "billions",
        "unit": "dollars",
        "confidence": 1,
        "quote_start_char": 4088,
        "metric_context": "Total",
        "quote_text": "Johnson & Johnson is the only healthcare company that will soon deliver more than $100 billion in annual revenue.",
        "claimed_value_raw": "$100 billion",
        "is_approximate": false,
        "claimed_value": 100,
        "period": "FY 2026",
        "claim_id": "claim_002",
        "claim_type": "guidance",
        "speaker_role": "ceo",
        "qualifiers": [
          "more than"
        ],
        "gaap_classification": "gaap",
        "speaker": "Joaquin Duato",
        "metric_type": "revenue"
      },
      "verification": {
        "claim_id": "claim_002",
        "claimed_value": 100,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "guidance_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Forward-looking guidance claims cannot be verified against historical data.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_type": "revenue",
        "claim_type": "absolute",
        "unit": "count",
        "scale": "ones",
        "quote_text": "In fact, we now have 28 platform-sold products that generate at least $1 billion of revenue annually, and that makes our growth more sustainable.",
        "claimed_value_raw": "28",
        "period": "FY 2025",
        "speaker": "Joaquin Duato",
        "is_approximate": false,
        "quote_start_char": 4417,
        "speaker_role": "ceo",
        "quote_end_char": 4562,
        "claim_id": "claim_003",
        "confidence": 1,
        "gaap_classification": "gaap",
        "claimed_value": 28,
        "metric_context": "Total",
        "qualifiers": []
      },
      "verification": {
        "claim_id": "claim_003",
        "claimed_value": 28,
        "actual_value": 94193000000.0,
        "difference": -94192999972.0,
        "difference_pct": 99.9999999702738,
        "tolerance_used": 0.005,
        "computation_detail": "Full-year revenue: claimed 28.00 vs actual 94,193,000,000.00. Diff: 100.00% (threshold: 0.5%).",
        "computation_steps": [
          {
            "step": "Full-year aggregation",
            "formula": "Q1 2025 + Q2 2025 + Q3 2025 + Q4 2025",
            "result": 94193000000.0
          }
        ],
        "financial_facts_used": [
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 1,
            "value": 21893000000
          },
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 2,
            "value": 23743000000
          },
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 3,
            "value": 23993000000
          },
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 4,
            "value": 24564000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [
          "conflicting_transcript_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Transcript contains conflicting values for this same metric and period. Another claim (claim_023) aligns with financial data, so this value is likely a transcript/source artifact.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "confidence": 1,
        "unit": "percent",
        "claimed_value_raw": "5.3%",
        "claim_type": "yoy_growth",
        "comparison_period": "FY 2024",
        "metric_type": "revenue",
        "period": "FY 2025",
        "gaap_classification": "non_gaap",
        "is_approximate": false,
        "qualifiers": [
          "operational"
        ],
        "quote_text": "Turning to our results, over the full year, we delivered 5.3% operational sales growth.",
        "claim_id": "claim_004",
        "scale": "ones",
        "quote_end_char": 4782,
        "claimed_value": 5.3,
        "quote_start_char": 4695,
        "speaker": "Joaquin Duato",
        "speaker_role": "ceo",
        "metric_context": "Total"
      },
      "verification": {
        "claim_id": "claim_004",
        "claimed_value": 5.3,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_context": "Innovative Medicine",
        "speaker": "Joaquin Duato",
        "claimed_value_raw": "5.3%",
        "unit": "percent",
        "comparison_period": "FY 2024",
        "scale": "ones",
        "quote_start_char": 4957,
        "quote_text": "In innovative medicine, we reported operational sales growth for the year of 5.3%.",
        "is_approximate": false,
        "period": "FY 2025",
        "confidence": 1,
        "quote_end_char": 5039,
        "speaker_role": "ceo",
        "claim_id": "claim_005",
        "qualifiers": [
          "reported operational sales growth"
        ],
        "claimed_value": 5.3,
        "metric_type": "revenue",
        "claim_type": "yoy_growth",
        "gaap_classification": "non_gaap"
      },
      "verification": {
        "claim_id": "claim_005",
        "claimed_value": 5.3,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "is_approximate": false,
        "gaap_classification": "gaap",
        "speaker": "Joaquin Duato",
        "quote_start_char": 5040,
        "unit": "dollars",
        "claimed_value": 60,
        "metric_context": "Pharmaceutical",
        "qualifiers": [
          "exceeded"
        ],
        "claim_id": "claim_006",
        "quote_text": "Full-year sales for our Pharmaceutical business exceeded $60 billion for the first time, with 13 brands growing double digits.",
        "scale": "billions",
        "period": "FY 2025",
        "confidence": 1,
        "claimed_value_raw": "$60 billion",
        "metric_type": "revenue",
        "quote_end_char": 5166,
        "claim_type": "absolute",
        "speaker_role": "ceo"
      },
      "verification": {
        "claim_id": "claim_006",
        "claimed_value": 60,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a Pharmaceutical revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "is_approximate": false,
        "scale": "ones",
        "quote_text": "In oncology, in 2025, we delivered 21% operational sales growth, and we expect to exceed $50 billion in annual sales by 2030.",
        "unit": "percent",
        "claim_type": "yoy_growth",
        "speaker": "Joaquin Duato",
        "gaap_classification": "non_gaap",
        "speaker_role": "ceo",
        "quote_start_char": null,
        "quote_end_char": null,
        "period": "FY 2025",
        "confidence": 1,
        "claim_id": "claim_007",
        "claimed_value": 21,
        "metric_type": "revenue",
        "claimed_value_raw": "21%",
        "metric_context": "Oncology",
        "qualifiers": [
          "operational sales growth"
        ],
        "comparison_period": "FY 2024"
      },
      "verification": {
        "claim_id": "claim_007",
        "claimed_value": 21,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_id": "claim_008",
        "quote_start_char": null,
        "quote_end_char": null,
        "quote_text": "In oncology, in 2025, we delivered 21% operational sales growth, and we expect to exceed $50 billion in annual sales by 2030.",
        "claimed_value": 50,
        "confidence": 1,
        "qualifiers": [
          "expect to exceed"
        ],
        "gaap_classification": "gaap",
        "speaker_role": "ceo",
        "scale": "billions",
        "unit": "dollars",
        "claimed_value_raw": "$50 billion",
        "period": "FY 2030",
        "is_approximate": false,
        "speaker": "Joaquin Duato",
        "metric_type": "revenue",
        "claim_type": "guidance",
        "metric_context": "Oncology"
      },
      "verification": {
        "claim_id": "claim_008",
        "claimed_value": 50,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "guidance_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Forward-looking guidance claims cannot be verified against historical data.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "unit": "dollars",
        "claim_type": "absolute",
        "qualifiers": [
          "over"
        ],
        "quote_text": "With annual sales over $14 billion, DARZALEX grew an impressive 22% across the full year.",
        "period": "FY 2025",
        "claimed_value_raw": "$14 billion",
        "is_approximate": false,
        "speaker_role": "ceo",
        "claim_id": "claim_009",
        "metric_context": "DARZALEX",
        "scale": "billions",
        "quote_end_char": 6241,
        "confidence": 1,
        "metric_type": "revenue",
        "quote_start_char": 6152,
        "claimed_value": 14,
        "speaker": "Joaquin Duato",
        "gaap_classification": "gaap"
      },
      "verification": {
        "claim_id": "claim_009",
        "claimed_value": 14,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a DARZALEX revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claimed_value_raw": "57%",
        "quote_start_char": 8825,
        "claim_type": "yoy_growth",
        "qualifiers": [],
        "comparison_period": "FY 2024",
        "scale": "ones",
        "is_approximate": false,
        "claimed_value": 57,
        "speaker_role": "ceo",
        "quote_text": "Spravato continues its strong trajectory with 57% growth in the year, with more than two hundred thousand patients now treated worldwide.",
        "speaker": "Joaquin Duato",
        "confidence": 1,
        "claim_id": "claim_011",
        "metric_context": "Spravato",
        "unit": "percent",
        "gaap_classification": "gaap",
        "metric_type": "revenue",
        "quote_end_char": 8962,
        "period": "FY 2025"
      },
      "verification": {
        "claim_id": "claim_011",
        "claimed_value": 57,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a Spravato revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [
          "operational sales for the year grew"
        ],
        "claimed_value": 5.4,
        "scale": "ones",
        "claim_id": "claim_012",
        "period": "FY 2025",
        "quote_start_char": null,
        "confidence": 1,
        "quote_end_char": null,
        "is_approximate": false,
        "comparison_period": "FY 2024",
        "speaker_role": "ceo",
        "speaker": "Joaquin Duato",
        "metric_context": "MedTech",
        "gaap_classification": "non_gaap",
        "quote_text": "Turning to MedTech, where operational sales for the year grew 5.4%.",
        "metric_type": "revenue",
        "claimed_value_raw": "5.4%",
        "unit": "percent",
        "claim_type": "yoy_growth"
      },
      "verification": {
        "claim_id": "claim_012",
        "claimed_value": 5.4,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "unit": "dollars",
        "period": "FY 2025",
        "claimed_value": 4,
        "gaap_classification": "gaap",
        "metric_type": "revenue",
        "confidence": 1,
        "claim_type": "absolute",
        "is_approximate": true,
        "quote_start_char": 9231,
        "metric_context": "MedTech",
        "scale": "billions",
        "claim_id": "claim_013",
        "qualifiers": [
          "nearly"
        ],
        "claimed_value_raw": "$4 billion",
        "speaker_role": "ceo",
        "quote_text": "In 2025, we delivered nearly $4 billion in sales, with strong performance in cardiovascular and accelerating momentum across surgery and vision.",
        "quote_end_char": 9375,
        "speaker": "Joaquin Duato"
      },
      "verification": {
        "claim_id": "claim_013",
        "claimed_value": 4,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a MedTech revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "quote_start_char": 9591,
        "claimed_value": 15,
        "unit": "percent",
        "gaap_classification": "non_gaap",
        "confidence": 1,
        "claim_type": "yoy_growth",
        "metric_context": "Cardiovascular",
        "scale": "ones",
        "is_approximate": false,
        "comparison_period": "FY 2024",
        "claim_id": "claim_014",
        "quote_text": "Johnson & Johnson today is a leader in three cardiovascular segments, with the portfolio delivering 15% operational sales growth in the year.",
        "qualifiers": [
          "operational sales growth"
        ],
        "claimed_value_raw": "15%",
        "period": "FY 2025",
        "speaker_role": "ceo",
        "quote_end_char": 9732,
        "speaker": "Joaquin Duato",
        "metric_type": "revenue"
      },
      "verification": {
        "claim_id": "claim_014",
        "claimed_value": 15,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "quote_text": "And finally, vision, which delivered robust annual operational sales growth of 5.3% with particularly strong momentum in surgical vision.",
        "metric_context": "Vision",
        "claimed_value_raw": "5.3%",
        "claim_id": "claim_016",
        "period": "FY 2025",
        "scale": "ones",
        "comparison_period": "FY 2024",
        "is_approximate": false,
        "quote_end_char": 11392,
        "speaker_role": "ceo",
        "unit": "percent",
        "gaap_classification": "non_gaap",
        "claim_type": "yoy_growth",
        "metric_type": "revenue",
        "speaker": "Joaquin Duato",
        "quote_start_char": 11255,
        "claimed_value": 5.3,
        "qualifiers": [
          "robust annual operational sales growth"
        ],
        "confidence": 1
      },
      "verification": {
        "claim_id": "claim_016",
        "claimed_value": 5.3,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "is_approximate": false,
        "claim_id": "claim_017",
        "claimed_value_raw": "$24.6 billion",
        "qualifiers": [
          "Worldwide sales"
        ],
        "quote_end_char": 12320,
        "period": "Q4 2025",
        "speaker_role": "management",
        "quote_text": "Worldwide sales were $24.6 billion for the quarter.",
        "metric_type": "revenue",
        "claimed_value": 24.6,
        "speaker": "Darren Snellgrove",
        "confidence": 1,
        "gaap_classification": "gaap",
        "claim_type": "absolute",
        "metric_context": "Total",
        "unit": "dollars",
        "scale": "billions",
        "quote_start_char": 12269
      },
      "verification": {
        "claim_id": "claim_017",
        "claimed_value": 24.6,
        "actual_value": 24564000000,
        "difference": 36000000.0,
        "difference_pct": 0.14655593551538837,
        "tolerance_used": 0.005,
        "computation_detail": "Claimed 24,600,000,000.00 vs Actual 24,564,000,000.00. Diff: 0.15% (threshold: 0.5%)",
        "computation_steps": [
          {
            "step": "Absolute comparison",
            "formula": "|24,600,000,000.00 - 24,564,000,000.00| / |24,564,000,000.00|",
            "result": 0.0014655593551538837,
            "threshold": 0.005
          }
        ],
        "financial_facts_used": [
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 4,
            "value": 24564000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Verified: claimed 24,600,000,000.00 vs actual 24,564,000,000.00 from fmp.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "gaap_classification": "gaap",
        "claimed_value_raw": "7.1%",
        "claim_type": "yoy_growth",
        "metric_type": "revenue",
        "quote_text": "Sales increased 7.1% despite an approximate 650 basis point headwind from STELARA.",
        "metric_context": "Total",
        "claimed_value": 7.1,
        "speaker": "Darren Snellgrove",
        "unit": "percent",
        "scale": "ones",
        "quote_end_char": 12404,
        "period": "Q4 2025",
        "speaker_role": "management",
        "quote_start_char": 12322,
        "confidence": 1,
        "comparison_period": "Q4 2024",
        "claim_id": "claim_018",
        "qualifiers": [],
        "is_approximate": false
      },
      "verification": {
        "claim_id": "claim_018",
        "claimed_value": 7.1,
        "actual_value": 24564000000,
        "difference": -1.9763765541740685,
        "difference_pct": 1.9763765541740685,
        "tolerance_used": 1.0,
        "computation_detail": "Claimed 7.1% YoY growth. Actual: (24,564,000,000 - 22,520,000,000) / 22,520,000,000 = 9.08%. Diff: 1.98 pp (threshold: 1.0 pp)",
        "computation_steps": [
          {
            "step": "YoY growth",
            "formula": "(24,564,000,000 - 22,520,000,000) / |22,520,000,000| * 100",
            "result": 9.076376554174068,
            "claimed": 7.1,
            "difference_pp": -1.9763765541740685
          },
          {
            "step": "Supplemental QoQ discrepancy",
            "formula": "(24,564,000,000 - 23,993,000,000) / |23,993,000,000| * 100",
            "result": 2.3798607927312134,
            "claimed": 7.1,
            "difference_pp": 4.720139207268787
          }
        ],
        "financial_facts_used": [
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 4,
            "value": 24564000000
          },
          {
            "field": "revenue",
            "fy": 2024,
            "fq": 4,
            "value": 22520000000
          }
        ],
        "evidence_source": "fmp (current), fmp (prior)",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Growth claim: 7.1% claimed. Computed from Q4 2025 (24,564,000,000) vs Q4 2024 (22,520,000,000) = 9.08% actual. Quarter-over-quarter reference: Q4 2025 vs Q3 2025 = 2.38% (4.72 pp from claimed growth).",
        "verdict": "close_match"
      }
    },
    {
      "claim": {
        "quote_end_char": 12746,
        "scale": "billions",
        "period": "Q4 2025",
        "metric_context": "Total",
        "speaker_role": "management",
        "is_approximate": false,
        "claim_id": "claim_019",
        "claimed_value_raw": "$5.1 billion",
        "confidence": 1,
        "claim_type": "absolute",
        "qualifiers": [
          "net earnings"
        ],
        "quote_start_char": 12633,
        "metric_type": "net_income",
        "claimed_value": 5.1,
        "speaker": "Darren Snellgrove",
        "unit": "dollars",
        "gaap_classification": "gaap",
        "quote_text": "For the quarter, net earnings were $5.1 billion, and diluted earnings per share was $2.1 versus $1.41 a year ago."
      },
      "verification": {
        "claim_id": "claim_019",
        "claimed_value": 5.1,
        "actual_value": 5116000000,
        "difference": -16000000.0,
        "difference_pct": 0.3127443315089914,
        "tolerance_used": 0.01,
        "computation_detail": "Claimed 5,100,000,000.00 vs Actual 5,116,000,000.00. Diff: 0.31% (threshold: 1.0%)",
        "computation_steps": [
          {
            "step": "Absolute comparison",
            "formula": "|5,100,000,000.00 - 5,116,000,000.00| / |5,116,000,000.00|",
            "result": 0.003127443315089914,
            "threshold": 0.01
          }
        ],
        "financial_facts_used": [
          {
            "field": "net_income",
            "fy": 2025,
            "fq": 4,
            "value": 5116000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Verified: claimed 5,100,000,000.00 vs actual 5,116,000,000.00 from fmp.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "is_approximate": false,
        "speaker_role": "management",
        "confidence": 1,
        "quote_text": "For the quarter, net earnings were $5.1 billion, and diluted earnings per share was $2.1 versus $1.41 a year ago.",
        "claim_id": "claim_020",
        "quote_start_char": 12633,
        "period": "Q4 2025",
        "claimed_value": 2.1,
        "claimed_value_raw": "$2.1",
        "metric_type": "eps_diluted",
        "qualifiers": [
          "diluted earnings per share was $2.1 versus $1.41 a year ago."
        ],
        "speaker": "Darren Snellgrove",
        "gaap_classification": "gaap",
        "claim_type": "absolute",
        "scale": null,
        "quote_end_char": 12746,
        "unit": "per_share",
        "metric_context": "Total"
      },
      "verification": {
        "claim_id": "claim_020",
        "claimed_value": 2.1,
        "actual_value": 2.1,
        "difference": 0.0,
        "difference_pct": 0.0,
        "tolerance_used": 0.005,
        "computation_detail": "EPS: claimed $2.10 vs actual $2.10. Diff $0.000 within $0.005 tolerance.",
        "computation_steps": [
          {
            "step": "EPS absolute comparison",
            "formula": "|2.10 - 2.10| = 0.000",
            "result": 0.0,
            "threshold": 0.005
          }
        ],
        "financial_facts_used": [
          {
            "field": "eps_diluted",
            "fy": 2025,
            "fq": 4,
            "value": 2.1
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Verified: claimed $2.10 matches actual $2.10.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "scale": "billions",
        "speaker_role": "management",
        "period": "Q4 2025",
        "quote_start_char": 12748,
        "is_approximate": false,
        "claim_id": "claim_021",
        "confidence": 1,
        "qualifiers": [
          "Adjusted net earnings"
        ],
        "claimed_value_raw": "$6 billion",
        "gaap_classification": "non_gaap",
        "metric_type": "net_income",
        "claim_type": "absolute",
        "metric_context": "Total",
        "unit": "dollars",
        "quote_text": "Adjusted net earnings for the quarter were $6 billion, and adjusted diluted earnings per share of $2.46, representing an increase of 21.5% compared to 2024.",
        "speaker": "Darren Snellgrove",
        "quote_end_char": 12904,
        "claimed_value": 6
      },
      "verification": {
        "claim_id": "claim_021",
        "claimed_value": 6,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "speaker_role": "management",
        "quote_start_char": 12748,
        "confidence": 1,
        "quote_text": "Adjusted net earnings for the quarter were $6 billion, and adjusted diluted earnings per share of $2.46, representing an increase of 21.5% compared to 2024.",
        "claimed_value_raw": "21.5%",
        "gaap_classification": "non_gaap",
        "unit": "percent",
        "qualifiers": [
          "adjusted diluted earnings per share of $2.46, representing an increase of 21.5% compared to 2024."
        ],
        "quote_end_char": 12904,
        "comparison_period": "Q4 2024",
        "claim_type": "yoy_growth",
        "speaker": "Darren Snellgrove",
        "period": "Q4 2025",
        "metric_type": "eps_diluted",
        "metric_context": "Total",
        "is_approximate": false,
        "scale": "ones",
        "claimed_value": 21.5,
        "claim_id": "claim_022"
      },
      "verification": {
        "claim_id": "claim_022",
        "claimed_value": 21.5,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "unit": "dollars",
        "confidence": 1,
        "claim_id": "claim_023",
        "speaker_role": "management",
        "quote_text": "For the full year 2025, worldwide sales were $94.2 billion.",
        "is_approximate": false,
        "period": "FY 2025",
        "metric_type": "revenue",
        "claimed_value_raw": "$94.2 billion",
        "quote_start_char": 13071,
        "gaap_classification": "gaap",
        "claimed_value": 94.2,
        "speaker": "Darren Snellgrove",
        "claim_type": "absolute",
        "metric_context": "Total",
        "quote_end_char": 13130,
        "qualifiers": [
          "worldwide sales"
        ],
        "scale": "billions"
      },
      "verification": {
        "claim_id": "claim_023",
        "claimed_value": 94.2,
        "actual_value": 94193000000.0,
        "difference": 7000000.0,
        "difference_pct": 0.007431550115189027,
        "tolerance_used": 0.005,
        "computation_detail": "Full-year revenue: claimed 94,200,000,000.00 vs actual 94,193,000,000.00. Diff: 0.01% (threshold: 0.5%).",
        "computation_steps": [
          {
            "step": "Full-year aggregation",
            "formula": "Q1 2025 + Q2 2025 + Q3 2025 + Q4 2025",
            "result": 94193000000.0
          }
        ],
        "financial_facts_used": [
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 1,
            "value": 21893000000
          },
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 2,
            "value": 23743000000
          },
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 3,
            "value": 23993000000
          },
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 4,
            "value": 24564000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Full-year claim verified against sum of Q1-Q4 2025 revenue.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "gaap_classification": "non_gaap",
        "speaker": "Darren Snellgrove",
        "claim_type": "yoy_growth",
        "metric_context": "Total",
        "qualifiers": [
          "adjusted diluted earnings per share was $10.79, both representing an increase of 8.1% compared to full year 2024."
        ],
        "quote_end_char": 14031,
        "scale": "ones",
        "unit": "percent",
        "speaker_role": "management",
        "comparison_period": "FY 2024",
        "confidence": 1,
        "claim_id": "claim_024",
        "is_approximate": false,
        "period": "FY 2025",
        "quote_text": "Full-year 2025 adjusted net earnings were $26.2 billion, and adjusted diluted earnings per share was $10.79, both representing an increase of 8.1% compared to full year 2024.",
        "claimed_value": 8.1,
        "quote_start_char": 13857,
        "claimed_value_raw": "8.1%",
        "metric_type": "eps_diluted"
      },
      "verification": {
        "claim_id": "claim_024",
        "claimed_value": 8.1,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claimed_value": 19.7,
        "claim_id": "claim_025",
        "speaker": "Joe Wolk",
        "quote_text": "The company generated $19.7 billion of free cash flow during 2025, on par with 2024 despite increased capital investment in the US and the impact of tariffs.",
        "period": "FY 2025",
        "metric_context": "Total",
        "claimed_value_raw": "$19.7 billion",
        "gaap_classification": "unknown",
        "speaker_role": "cfo",
        "unit": "dollars",
        "metric_type": "free_cash_flow",
        "is_approximate": false,
        "qualifiers": [],
        "scale": "billions",
        "quote_end_char": 22216,
        "confidence": 1,
        "claim_type": "absolute",
        "quote_start_char": 22059
      },
      "verification": {
        "claim_id": "claim_025",
        "claimed_value": 19.7,
        "actual_value": 8513000000.0,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [
          {
            "field": "free_cash_flow",
            "fy": 2025,
            "fq": 1,
            "value": 3365000000
          },
          {
            "field": "free_cash_flow",
            "fy": 2025,
            "fq": 2,
            "value": 2480000000
          },
          {
            "field": "free_cash_flow",
            "fy": 2025,
            "fq": 3,
            "value": 8381000000
          },
          {
            "field": "free_cash_flow",
            "fy": 2025,
            "fq": 4,
            "value": -5713000000.0
          }
        ],
        "evidence_source": "fmp, sec_companyfacts",
        "flags": [
          "value_exceeds_actual"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Claimed value (19,700,000,000) is 2.3x the reported free cash flow (8,513,000,000). This likely reflects a different time period (TTM, annual, or fiscal year offset) or includes items beyond this metric.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_id": "claim_026",
        "unit": "dollars",
        "metric_context": "Total",
        "scale": "billions",
        "is_approximate": true,
        "claimed_value_raw": "$21 billion",
        "period": "FY 2026",
        "quote_text": "As we move forward in 2026, we expect to elevate free cash flow generation to approximately $21 billion.",
        "gaap_classification": "unknown",
        "claimed_value": 21,
        "qualifiers": [
          "approximately"
        ],
        "quote_start_char": 22350,
        "confidence": 1,
        "quote_end_char": 22454,
        "speaker_role": "cfo",
        "metric_type": "free_cash_flow",
        "claim_type": "guidance",
        "speaker": "Joe Wolk"
      },
      "verification": {
        "claim_id": "claim_026",
        "claimed_value": 21,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "guidance_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Forward-looking guidance claims cannot be verified against historical data.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "period": "FY 2026",
        "qualifiers": [
          "midpoint of $100 billion"
        ],
        "quote_text": "We anticipate operational sales growth in the range of 5.7% to 6.7% with a midpoint of $100 billion or 6.2%.",
        "unit": "percent",
        "quote_start_char": 22677,
        "claim_type": "guidance",
        "metric_type": "revenue",
        "speaker": "Joe Wolk",
        "scale": "ones",
        "quote_end_char": 22785,
        "metric_context": "Total",
        "claim_id": "claim_027",
        "claimed_value": 6.2,
        "claimed_value_raw": "6.2%",
        "gaap_classification": "non_gaap",
        "speaker_role": "cfo",
        "confidence": 1,
        "is_approximate": false
      },
      "verification": {
        "claim_id": "claim_027",
        "claimed_value": 6.2,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [
          "midpoint for a range of $11.28 to $11.48."
        ],
        "quote_text": "Turning to adjusted operational earnings per share, we expect growth of 5.5% at the midpoint for a range of $11.28 to $11.48.",
        "quote_end_char": 25192,
        "scale": "ones",
        "gaap_classification": "non_gaap",
        "claimed_value": 5.5,
        "period": "FY 2026",
        "claim_id": "claim_028",
        "speaker_role": "cfo",
        "is_approximate": false,
        "quote_start_char": 25067,
        "claimed_value_raw": "5.5%",
        "confidence": 1,
        "metric_context": "Total",
        "claim_type": "guidance",
        "metric_type": "eps_diluted",
        "speaker": "Joe Wolk",
        "unit": "percent"
      },
      "verification": {
        "claim_id": "claim_028",
        "claimed_value": 5.5,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [
          "approximately"
        ],
        "period": "Q4 2025",
        "comparison_period": "Q4 2024",
        "is_approximate": true,
        "quote_text": "Abiomed and Shockwave performed particularly well, delivering operational growth of approximately 1823% in the quarter.",
        "quote_start_char": 9733,
        "claim_id": "claim_015",
        "metric_context": "Abiomed and Shockwave",
        "unit": "percent",
        "confidence": 0.8,
        "speaker": "Joaquin Duato",
        "claim_type": "yoy_growth",
        "speaker_role": "ceo",
        "claimed_value": 1823,
        "quote_end_char": 9852,
        "metric_type": "revenue",
        "scale": "ones",
        "gaap_classification": "non_gaap",
        "claimed_value_raw": "1823%"
      },
      "verification": {
        "claim_id": "claim_015",
        "claimed_value": 1823,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    }
  ],
  "summary": {
    "total": 27,
    "verified": 4,
    "close_match": 1,
    "mismatch": 0,
    "misleading": 0,
    "unverifiable": 22
  }
}